drugset / Trial / NCT01944852

Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental PD.

NCT01944852

Phase 4 Completed 117 enrolled Pr Eric Goffin
RandomizedParallel-groupOpen-labelTreatment

Summary

The DIDo study is an open-label, randomised, multicentre study with 2 parallel groups in incident CAPD patients aged of 65 at minimum : * One group in which patients will receive 2 bags of icodextrin/day and 1 bag of glucose * One group in which patients will receive 1 bag of icodextrin/day and 2 bags of glucose.

Timeline

Start
2013-03
Primary completion
2020-02-28
Completion
2020-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Icodextrin Other / unclassified 1 unknown
Subject Icodextrin Other / unclassified 2 unknown